Next-generation Sequencing in Understanding Complex Neurological Disease
Overview
Pharmacology
Affiliations
Next-generation sequencing techniques have made vast quantities of data on human genomes and transcriptomes available to researchers. Huge progress has been made towards understanding the basis of many Mendelian neurological conditions, but progress has been considerably slower in complex neurological diseases (multiple sclerosis, migraine, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and so on). The authors review current next-generation sequencing methodologies and present selected studies illustrating how these have been used to cast light on the genetic etiology of complex neurological diseases with specific focus on multiple sclerosis. The authors highlight particular pitfalls in next-generation sequencing experiments and speculate on both clinical and research applications of these sequencing platforms for complex neurological disorders in the future.
Ruffo P, Traynor B, Conforti F J Neurol. 2025; 272(3):233.
PMID: 40009238 PMC: 11865122. DOI: 10.1007/s00415-025-12975-8.
Expression patterns of AEG-1 in the normal brain.
Kim H, Choi M, Han S, Park S, Jeong M, Kim S Brain Struct Funct. 2023; 228(7):1629-1641.
PMID: 37421418 DOI: 10.1007/s00429-023-02676-1.
A Systems Biology Approach for Personalized Medicine in Refractory Epilepsy.
Naimo G, Guarnaccia M, Sprovieri T, Ungaro C, Conforti F, Ando S Int J Mol Sci. 2019; 20(15).
PMID: 31366017 PMC: 6695675. DOI: 10.3390/ijms20153717.
Cho Y, Lee S, Hong J, Kim B, Hong W, Jung J Nucleic Acids Res. 2018; 46(15):e92.
PMID: 29873758 PMC: 6125643. DOI: 10.1093/nar/gky445.
Detection of genomic rearrangements from targeted resequencing data in Parkinson's disease patients.
Spataro N, Roca-Umbert A, Cervera-Carles L, Valles M, Anglada R, Pagonabarraga J Mov Disord. 2017; 32(1):165-169.
PMID: 28124432 PMC: 5297984. DOI: 10.1002/mds.26845.